natgillin/translations-raw huggingface dataset:
Vaccinen vil blive givet ved at trykke forsigtigt på tuben og indgive vaccinen i barnets mund.
The vaccine will be given by gently squeezing the tube and delivering the vaccine into your child’s mouth.
Vaccinen vil blive indsprøjtet i en muskel.
It will be injected into a muscle.
Vaccinen vil muligvis ikke forebygge hepatitis B i sådanne tilfælde.
The vaccine may not prevent hepatitis B in these individuals.
Vaccinen virker ved at hjælpe kroppen med at danne sine egne antistoffer, som beskytter Deres barn mod disse sygdomme.
The vaccine works by helping the body to make its own antibodies, which protect your child against these diseases.
Vaccinen virker ved at hjælpe kroppen til selv at producere beskyttelse (antistoffer) mod virus.
Fendrix helps your body to produce its own protection against the virus (antibodies).
Vaccinen virker ved specifikt at stimulere kroppens naturlige forsvarssystem hos den vaccinerede person.
The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated person.
Vaccinen viste sig også at være sikker til diegivende moderfår og køer.
Vaccination was also shown to be safe for use during lactation in ewes and cattle.
Vaccinens effekt (95 % CI)
Vaccine efficacy
Vaccinens effekt blev dokumenteret ved påvisning af immunologisk non-inferioritet (baseret overvejende på sammenligning af andele med rSBA-titre på mindst 8) i forhold til godkendte meningokokvacciner.
Vaccine efficacy was inferred from the demonstration of immunologic non inferiority (based mainly on comparing proportions with rSBA titres at least 8) to licensed meningococcal vaccines.
Vaccinens effekt blev påvist i en feltundersøgelse, hvor hunde naturligt blev eksponeret for
The efficacy of the vaccine was demonstrated in a field study where dogs were naturally exposed to
Vaccinens effektivitet af acellulær pertussis- (aP) antigener i Hexacima, i forhold til den sværeste WHO-definerede, typiske pertussis (≥ 21 dages paroxysmal hoste) er dokumenteret i et randomiseret dobbeltblindt studie blandt spædbørn med primærserie på 3 doser ved brug af en DTaP-vaccine i et højt-endemisk land (Senegal).
Vaccine efficacy of the acellular pertussis (aP) antigens contained in Hexacima against the most severe WHO-defined typical pertussis ( 21 days of paroxysmal cough) is documented in a randomised double-blind study among infants with a 3 dose primary series using a DTaP vaccine in a highly endemic country (Senegal).
Vaccinens effektivitet af acellulær pertussis- (aP) antigener i Hexyon, i forhold til den sværeste WHO- definerede, typiske pertussis (≥ 21 dages paroxysmal hoste) er dokumenteret i et randomiseret dobbeltblindt studie blandt spædbørn med primærserie på 3 doser ved brug af en DTaP-vaccine i et højt-endemisk land (Senegal).
Vaccine efficacy of the acellular pertussis (aP) antigens contained in Hexyon against the most severe WHO-defined typical pertussis ( 21 days of paroxysmal cough) is documented in a randomised double-blind study among infants with a 3 dose primary series using a DTaP vaccine in a highly endemic country (Senegal).
Vaccinens estimerede effekt mod alle kliniske tilfælde af otitis media uanset ætiologi var 33,6 % (95 % CI 20,8;44,3).
The estimated vaccine efficacy against any clinical episodes of otitis media regardless of aetiology was 33.6% (95% CI: 20.8; 44.3).
Vaccinens evne til at yde beskyttelse mod homologe og heterologe virusstammer er vurderet præ- klinisk for A/Indonesia/05/05 (H5N1) ud fra et forsøg med fritter.
The ability to induce protection against homologous and heterologous vaccine strains was assessed non-clinically with A/Indonesia/05/05 (H5N1) using ferret challenge models.
Vaccinens evne til at yde beskyttelse mod homologe og heterologe virusstammer er vurderet præ- klinisk ud fra et belastningsforsøg med fritter.
The ability to induce protection against homologous and heterologous vaccine strains was assessed non- clinically using ferret challenge models.
Vaccinens evne til at yde beskyttelse mod homologe og heterologe virusstammer er vurderet præ- klinisk ud fra et belastningsforsøg med fritter.
The ability to induce protection against homologous and heterologous vaccine strains was assessed non-clinically using ferret challenge models.
Vaccinens immunogenicitet blev evalueret i en randomiseret, aktivt kontrolleret, observatørblindet, fase 3- multicenterundersøgelse med deltagelse af 867 raske mandlige og kvindelige forsøgspersoner, der fik indgivet IXIARO eller den USA-godkendte vaccine mod japansk encefalitisvirus JE-VAX (ved subkutan injektion på dag 0, 7 og 28).
Immunogenicity of the vaccine was evaluated in a randomized, active controlled, observer blinded, multicenter Phase 3 clinical trial including 867 healthy male and female subjects given IXIARO or the US licensed JEV vaccine JE VAX (on a 0, 7 and 28 day schedule by subcutaneous injection).
Vaccinens navn og partinummer skal registreres vha. mærkaterne leveret med pakken, som indeholder hætteglas med både antigen og adjuvans for at sikre sporbarheden af det produkt den vaccinerede person har fået.
In order to keep the traceability of the product received by each vaccinee the name of the vaccine and the lot number should be recorded by using the stickers provided in the pack containing both the antigen and adjuvant vials.
Vaccinens primære effektmål var viræmi og kliniske symptomer hos de dyr, som var genstand for undersøgelsen.
The main measures of the efficacy of the vaccine were viraemia and clinical signs in animals that took part in the studies.
Vaccinens sikkerhed blev undersøgt i forbindelse med en række laboratorieundersøgelser af kvæg og får i en alder af mindst 2,5 måned samt af drægtige moderfår og køer.
The safety of the vaccine was studied in several laboratory studies in cattle and sheep at the minimum age of two and a half months and during pregnancy in ewes and cows.
Vaccinens sikkerhed er testet i kyllinger, og der er kun støttende data om sikkerheden hos ænder tilgængelig.
This vaccine has been tested for safety in chickens and only supportive data for safety in ducks are available.
Vaccinens sikkerhed og virkning er endnu ikke fastlagt hos avlshanner.
The safety and the efficacy of the vaccine have not been established in breeding males.
Vaccinens sikkerhed og virkning er ikke blevet fastlagt hos diegivende dyr.
The safety and the efficacy of the vaccine have not been established in lactating animals.
Vaccinens sikkerhed og virkning under laktation er ikke fastlagt.
The safety and the efficacy of the vaccine have not been established during lactation.
Vaccinens sikkerhed og virkning ved samtidig brug af andre vacciner (enten samme dag eller på andre tidspunkter) er derfor ikke påvist.
Therefore the safety and efficacy of this product when used with any other (either when used on the same day or at different times) has not been demonstrated
Vaccinens stabilitet ved brug er dog vist at være 30 minutter, når den opbevares ved 20 C - 25 C.
However, in-use stability has been demonstrated for 30 minutes when stored at 20C – 25C.
Vaccinens virkning = (1 - relativ risiko) x 100 %
Vaccine Efficacy = (1 - Relative Risk) x 100
Vaccinens virkning = (1 - relativ risiko) x 100 %;
Vaccine Efficacy = (1 - Relative Risk) x 100 %;
Vaccinens virkning blev først undersøgt hos svin i en række laboratorieundersøgelser.
The effectiveness of the vaccine was first studied in a number of laboratory studies in pigs.
Vaccinens virkning blev påvist i forbindelse med en række laboratorieundersøgelser af får og kvæg i den anbefalede minimumsalder.
The efficacy of the vaccine was demonstrated in a number of laboratory trials in sheep and cattle of the minimum recommended age.
Vaccinens virkning blev vurderet i én hovedundersøgelse, der omfattede 2 654 voksne, hvoraf ca. halvdelen var ældre personer (over 60 år).
The vaccine’s effectiveness was assessed in one main study involving 2,654 adults, around half of whom were elderly (over 60 years of age).
Vaccinens virkning hos får blev undersøgt i en pivotal laboratorieundersøgelse, hvor vaccinen blev brugt på får fra en ung alder.
The effectiveness of the vaccine in sheep was studied in a pivotal laboratory trial using the vaccine in sheep from a young age.
Vaccinens virkning mod influenzavirusstammer, der matcher vaccinen, mod alle influenzavirusstammer og mod de enkelte undertyper af influenzavirus blev beregnet (tabel 2 og 3).
Vaccine efficacies against vaccine-matched influenza viral strains, against all influenza viral strains, and against individual influenza viral subtypes were calculated (Tables 2 and 3).
Vaccinens virkning*
Vaccine Efficacy
Vacciner fungerer ved at 'lære' immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner fungerer ved at lære kroppens immunsystem (det naturlige forsvar), hvordan det forsvarer sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner fungerer ved at lære kroppens naturlige forsvar (immunsystemet), hvordan det forsvarer sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner fungerer ved at lære kroppens naturlige forsvar, også kaldet immunsystemet, hvordan det forsvarer sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner fungerer ved at lære kroppens naturlige forsvar, også kaldet immunsystemet, hvordan det forsvarer sig mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner fungerer ved at ”lære” kroppens naturlige forsvar (immunsystemet), hvordan det forsvarer sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner kun raske dyr
Vaccinate only healthy animals.
Vacciner mod serogruppe A, C, Y, W-135 og B (hvis tilgængelig) anbefales til forebyggelse af de normalt patogene meningokok-serogrupper (se Meningokokinfektion).
Vaccines against serotypes A, C, Y, W135 and B where available are recommended in preventing the commonly pathogenic meningococcal serotypes. (see Meningococcal Infection).
Vacciner mod serogruppe A, C, Y, W-135 og B (hvis tilgængelig) anbefales til forebyggelse af de normalt patogene meningokok-serogrupper.
Vaccines against serotypes A, C, Y, W135 and B where available, are recommended in preventing the commonly pathogenic meningococcal serotypes.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal beskytte sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod sygdommen.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at "lære" immunsystemet (kroppens naturlige immunforsvar), hvordan det forsvarer sig mod en specifik sygdom.
A vaccine against a specific disease ‘teaches’ the immune system (the body’s natural defences) to defend itself against the disease.
Vacciner virker ved at "lære" immunsystemet (organismens naturlige forsvar), hvordan det skal for- svare organismen mod sygdommen.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (organismens naturlige forsvar), hvordan det skal forsvare organismen mod sygdomme.
Vaccines work by priming the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at "lære" immunsystemet (organismens naturlige forsvar), hvordan det skal forsvare organismen mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at "lære" immunsystemet (organismens naturlige forsvar), hvordan det skal forsvare organismen mod sygdommen.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet (organismens naturlige forsvar), hvordan det skal forsvare sig imod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet, hvordan det skal forsvare sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system how to defend itself against a disease.
Vacciner virker ved at "lære" immunsystemet, hvordan det skal forsvare sig mod sygdomme.
Vaccines work by ‘teaching’ the immune system how to defend itself against diseases.
Vacciner virker ved at "lære" kroppens naturlige forsvar, immunsystemet, hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at "lære" organismens naturlige forsvar (immunsystemet) at forsvare organismen mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) to defend itself against diseases.
Vacciner virker ved at "lære" organismens naturlige forsvar, immunsystemet, hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at »lære« immunsystemet (kroppens naturlige forsvar), hvordan det skal beskytte sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at »lære« immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at »lære« immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at »lære« organismens naturlige forsvar, immunsystemet, hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at ‘lære’ immunsystemet (kroppens naturlige forsvar), hvordan det skal beskytte sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at ‘lære’ immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at ‘lære’ immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare kroppen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner virker ved at ‘lære’ immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at “lære” kroppens naturlige forsvar, immunsystemet, hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at “lære” organismens naturlige forsvar (immunsystemet), hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at “lære” organismens naturlige forsvar, immunsystemet, hvordan det skal forsvare organismen mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at ”lære” immunsystemet (kroppens naturlige forsvar), hvordan det skal beskytte sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved at ”lære” immunsystemet (kroppens naturlige forsvar), hvordan det skal beskytte sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to protect itself against a disease.
Vacciner virker ved at ”lære” immunsystemet (kroppens naturlige forsvar), hvordan det skal forsvare sig mod en sygdom.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved, at de "lærer" immunsystemet (organismens naturlige forsvar), hvordan det skal forsvare organismen mod sygdommen.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease.
Vacciner virker ved, at de ‘lærer’ immunsystemet (kroppens naturlige forsvarssystem), hvordan det skal forsvare sig selv mod sygdomme.
Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against diseases.
Vacciner, som indeholder vaccinia-vira, blev brugt på effektiv vis i kampagnen for at udrydde kopper.
Vaccines containing vaccinia viruses were used effectively in the campaign to eradicate smallpox.
Vacciner: De må ikke få Savene, hvis De skal vaccineres mod gul feber, og det anbefales, at De ikke får Savene, hvis De skal vaccineres med en vaccine, der indeholder levende virus.
Vaccines: you must not use Savene if you are going to receive yellow fever vaccine and it is not recommended that you use Savene if you are going to receive a vaccine containing live virus particles.
Vaccinerede fugle kan udskille vaccinestammen via fæces i op til 5 uger (kylling) eller 7 dage (kalkun) efter vaccination og vaccinen kan forekomme i miljøet indtil slutningen af slutfedningsperioden (kylling) eller 7 dage (kalkun).
Vaccinated birds may excrete the vaccine strain by faecal route for up to 5 weeks (chickens) or 7 days (turkeys) post vaccination and the vaccine may remain present in the environment until the end of the finishing or rearing period (chickens) or for 7 days (turkeys).
Vaccinerede hunde bør derfor holdes adskilt fra andre hunde- og kattearter efter vaccinationen.
Therefore vaccinated dogs should be separated from other canine and feline species after vaccination.
Vaccinerede smågrise kan udskille vaccinestammen i mindst 14 dage efter vaccination.
The vaccine strain may be excreted by vaccinated piglets for at least 14 days following vaccination.
Vaccineresponset blev defineret som andelen af personer med: rSBA-titre ≥ 32 for initielt seronegative personer (dvs. med rSBA-titer < 8 før vaccination) en mindst 4-dobbelt stigning i rSBA-titrene fra præ- til post-vaccination hos initielt seronegativepersoner (dvs. med rSBA-titer ≥ 8 før vaccination)
The vaccine response was defined as the proportion of subjects with: rSBA titres  32 for initially seronegative subjects (i.e., pre-vaccination rSBA titre < 8) at least a 4-fold increase in rSBA titres from pre- to post-vaccination for initially seropositive subjects (i.e., pre-vaccination rSBA titre ≥ 8)
Vaccineserotyper: 76 %
Vaccine serotypes: 76
Vaccineserotyper: 98 %
Vaccine serotypes: 98
Vaccinestammen er resistent over for aminoglykosider, sulfonamider, flumequin og trimethoprim sulfa kombinationer.
The vaccine strain is sensitive to penicillins, tetracyclines, macrolides and lincomycin.
Vaccinestammen kan identificeres ved dens vækstegenskaber på biologiske vækstmedier: den udviser normal vækst på MacConkey og trypticase- sojaagar, medens der ikke kan observeres kolonier på plader uden aromatiske aminosyrer (minimumagar).
The vaccine strain can be identified by its growth properties on biological growth media: it shows normal growth on MacConkey and trypticase soy agar, while no colonies are observed when plated without aromatic amino acids (minimum agar).
Vaccinestammen kan let spredes til andre svin, der er i kontakt med vaccinerede svin.
The vaccine strain readily spreads to other pigs in contact to vaccinated pigs.
Vaccinestammen vCP2017 er rekombinant canarypox virus, der afgiver preM/E gener af West Nile virus.
The vaccine strain vCP2017 is a recombinant canarypox virus expressing the preM/E genes of West Nile virus.
Vaccinestammen vCP2017 i Proteq West Nile er en canarypox-virus, der fungerer som ”bærer”, og som har fået et gen, der sætter den i stand til at producere den del af West Nile-virussen, der består af proteinerne PreM og E. Canarypox-virussen spreder sig ikke og deler sig ikke hos de vaccinerede heste.
The vaccine strain vCP2017 in Proteq West Nile is a ‘carrier’ canarypox virus that has been given a gene that makes it able to produce part of the West Nile virus, the proteins PreM and E. The canarypox viruses do not spread or multiply in the vaccinated horses.
Vaccinestammen vCP65 i Purevax Rabies er en ‘bærer’ af canarypox virus, som har fået tilført et gen, der gør det i stand til at danne dele af et rabiesvirus kaldet ‘glykoprotein G’.
The vaccine strain vCP65 in Purevax Rabies is a ‘carrier’ canarypox virus that has been given a gene that makes it able to produce part of a rabies virus called ‘glycoprotein G’.
Vaccinestammerne kan inficere får og svin, når vaccinen er administreret intranasalt, men ingen bivirkninger eller spredning til kontaktdyr er blevet påvist.
The vaccine strains are able to infect sheep and swine when administered intranasally, but no adverse reactions or spreading to in-contact animals occurred.
Vaccinestammerne vCP2242 og vCP3011 er rekombinant canarypox virus der afgiver hæmagglutinin HA genet fra hhv. influenza virusstammerne A/eq/Ohio/03 (amerikansk stamme, Florida undergruppe clade 1) og A/eq/Richmond/1/07 (amerikansk stamme, Florida undergruppe clade 2) hos hest.
The vaccine strains vCP2242 and vCP3011 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/eq/Ohio/03 (American strain, Florida sublineage clade 1) and A/eq/Richmond/1/07 (American strain, Florida sublineage clade2), respectively.